USP Drug Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

 Analgesics
 Anesthetics
 Anti-Addiction/Substance Abuse Treatment Agents
 Antibacterials
 Anticonvulsants
 Antidementia Agents
 Antidepressants
 Antiemetics
 Antifungals
 Antigout Agents
 Anti-inflammatory Agents
 Antimigraine Agents
 Antimyasthenic Agents
 Antimycobacterials
 Antineoplastics
   Alkylating Agents
   Antiandrogens
   Antiangiogenic Agents
   Antiestrogens/Modifiers
   Antimetabolites
   Aromatase Inhibitors, 3rd Generation
   Enzyme Inhibitors
   Molecular Target Inhibitors
   Monoclonal Antibody/Antibody-Drug Conjugate
     Bevacizumab
     Blinatumomab
     Daratumumab
     Dinutuximab
     Elotuzumab
     Ipilimumab
     Pertuzumab
     Trastuzumab
     Cetuximab
     Necitumumab
     Panitumumab
     Olaratumab
     Atezolizumab
     Avelumab
     Cemiplimab-rwlc
     Durvalumab
     Nivolumab
       D10316  Nivolumab (USAN/INN)
     Pembrolizumab
     Obinutuzumab
     Ofatumumab
     Rituximab
     Rituximab/ Hyaluronidase
     Ado-Trastuzumab Emtansine
     Brentuximab Vedotin
     Inotuzumab Ozogamicin
   Retinoids
   Treatment Adjuncts
   Antineoplastics, Other
 Anti-Obesity Agents
 Antiparasitics
 Antiparkinson Agents
 Antipsychotics
 Antispasticity Agents
 Antivirals
 Anxiolytics
 Bipolar Agents
 Blood Glucose Regulators
 Blood Products and Modifiers
 Cardiovascular Agents
 Central Nervous System Agents
 Contraceptives
 Dental and Oral Agents
 Dermatological Agents
 Electrolytes/Minerals/Metals/Vitamins
 Gastrointestinal Agents
 Genetic or Enzyme Disorder: Replacement, Modifiers, Treatment
 Genitourinary Agents
 Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
 Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
 Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
 Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
 Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
 Hormonal Agents, Suppressant (Adrenal)
 Hormonal Agents, Suppressant (Pituitary)
 Hormonal Agents, Suppressant (Thyroid)
 Immunological Agents
 Infertility Agents
 Inflammatory Bowel Disease Agents
 Metabolic Bone Disease Agents
 Ophthalmic Agents
 Otic Agents
 Respiratory Tract/Pulmonary Agents
 Sexual Disorder Agents
 Skeletal Muscle Relaxants
 Sleep Disorder Agents

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: June 17, 2019
According to the USP Drug Classification 2019

» Japanese version